Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 CHF | +9.97% | +19.05% | +63.04% |
Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
Sales 2024 * | - | Sales 2025 * | 20M 22.04M | Capitalization | 9.62M 10.6M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.61M | Net income 2025 * | 13M 14.33M | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 400K | Net cash position 2025 * | 7.23M 7.96M | EV / Sales 2025 * | 0.12 x |
P/E ratio 2024 * |
-0.83
x | P/E ratio 2025 * |
0.36
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
1 day | +9.97% | ||
1 week | +19.05% | ||
Current month | +22.95% | ||
1 month | -41.86% | ||
3 months | -3.60% | ||
6 months | +50.00% | ||
Current year | +63.04% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.075 | +9.97% | 688,344 |
24-05-03 | 0.0682 | +3.96% | 841,127 |
24-05-02 | 0.0656 | +7.54% | 465,421 |
24-04-30 | 0.061 | -3.17% | 3,774,330 |
Delayed Quote Swiss Exchange, May 06, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.04% | 10.62M | |
+22.81% | 46.81B | |
+46.56% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- ADXN Stock